Confirmatory testing in primary aldosteronism: Extensive medication switching is not needed in all patients

European Journal of Endocrinology

Volumn 166, Issue 4, 2012, Pages 679-686

  Solar, Miroslav ^a   Malirova, Eva ^a   Ballon, Marek ^a   Pelouch, Radek ^a   Ceral, Jiri ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMILORIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; LOOP DIURETIC AGENT; POTASSIUM; SODIUM; THIAZIDE DIURETIC AGENT; VERAPAMIL;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE RELEASE; ARTICLE; BLOOD PRESSURE MONITORING; CONFIRMATORY TEST; CONTROLLED STUDY; DIAGNOSTIC TEST; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DRUG INDUCED HEADACHE; DYSPNEA; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALE; PERIPHERAL EDEMA; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; REFERENCE VALUE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPRODUCIBILITY; SALT INTAKE; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ALDOSTERONE; ALDOSTERONE ANTAGONISTS; ALGORITHMS; ANTIHYPERTENSIVE AGENTS; DIAGNOSTIC TECHNIQUES, ENDOCRINE; DIURETICS; DRUG SUBSTITUTION; FEMALE; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; NEEDS ASSESSMENT; RENIN-ANGIOTENSIN SYSTEM; VALIDATION STUDIES AS TOPIC; YOUNG ADULT;

EID: 84859403815     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0914     Document Type: Article

References (11)

1. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME & Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. Journal of the American College of Cardiology 2005 45 1243-1248. (doi:10.1016/j.jacc.2005.01.015)
2. Sechi LA, Novello M, Lapenna R, Baroselli S, Nadalini E, Colussi GL & Catena C. Long-term renal outcomes in patients with primary aldosteronism. Journal of the American Medical Association 2006 295 2638-2645. (doi:10.1001/jama.295.22.2638)
3. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr & Montori VM. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 3266-3281. (doi:10.1210/jc.2008-0104)
4. Ceral J, Malirova E, Kopecka P, Pelouch R & Solar M. The effect of oral sodium loading and saline infusion on direct active renin in healthy volunteers. Acta Endocrinologica 2011 7 33-38. (doi:10.4183/aeb.2011.33)
5. Solar M, Ceral J, Krajina A, Ballon M, Malirova E, Brodak M &Cap J. Adrenal venous sampling: where is the aldosterone disappearing to? Cardiovascular and Interventional Radiology 2010 33 760-765. (doi:10.1007/s00270-009-9722-4)
6. Mulatero P, Milan A, Fallo F, Regolisti G, Pizzolo F, Fardella C, Mosso L, Marafetti L, Veglio F & Maccario M. Comparison of confirmatory tests for the diagnosis of primary aldosteronism. Journal of Clinical Endocrinology and Metabolism 2006 91 2618-2623. (doi:10.1210/jc.2006-0078)
7. Loh KC, Koay ES, Khaw MC, Emmanuel SC & Young WF Jr. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. Journal of Clinical Endocrinology and Metabolism 2000 85 2854-2859. (doi:10.1210/jc.85.8. 2854)
8. Stowasser M, Gordon RD, Rutherford JC, Nikwan NZ, Daunt N &Slater GJ. Diagnosis and management of primary aldosteronism. Journal of Renin-Angiotensin-Aldosterone System 2001 2 156-169. (doi:10.3317/jraas.2001. 022)
9. Rossi GP, Belfiore A, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Palumbo G, Rizzoni D, Rossi E, Agabiti-Rosei E, Pessina AC &Mantero F. Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 2007 50 424-431. (doi:10.1161/HYPERTENSIONAHA.107.091827)
10. Schirpenbach C, Seiler L, Maser-Gluth C, Rudiger F, Nickel C, Beuschlein F & Reincke M. Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites. European Journal of Endocrinology 2006 154 865-873. (doi:10.1530/eje.1.02164)
11. Schirpenbach C, Seiler L, Maser-Gluth C, Beuschlein F, Reincke M & Bidlingmaier M. Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps. Clinical Chemistry 2006 52 1749-1755. (doi:10.1373/clinchem.2006.068502)